Can a video call help parents of fussy babies at risk for ADHD?

NCT ID NCT05903053

Ongoing Symptom relief Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tests a telehealth-delivered training program for caregivers of infants (12-18 months old) who show early signs of ADHD, such as trouble with self-control or emotion regulation. The program teaches caregivers strategies to support their child's development through video coaching sessions. Only 8 families are enrolled, and the study focuses on whether the program is feasible and acceptable, not on curing ADHD.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Early Self-Regulation Intervention (behavioral training for caregivers delivered via telehealth)
What this could lead to: If successful, this could point toward a practical, home-based way to help caregivers support infants with early self-regulation difficulties, potentially reducing later ADHD symptoms.
What could go wrong: This is a very small pilot study (8 participants) with no control group, so results may not apply broadly. The intervention is still in early testing and may not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit-hyperactivity disorder Emotional Regulation Infant Behavior Self-Control

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFANT BEHAVIOR INFANT DEVELOPMENT SELF-CONTROL SELF-REGULATION, EMOTION

Contacts and locations

Locations

UC Davis MIND Institute

Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.